
    
      After being informed about the study and potential risks, all participants giving written
      informed consent will be screened for eligibility for study entry and will be randomized in a
      double-blind manner to receive either a multistrain probiotic or a placebo for 3 months. At
      entry, 1 week after inclusion, 4 weeks after inclusion and 3 months (end of study) vagal
      activity will be measured using a 24hr electrocardiogram.
    
  